| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0082 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0032 | 1 |